Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Capstone Clinical Research
1717
mi
from 91732
Libertyville, IL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Capstone Clinical Research
1717
mi
from 91732
Libertyville, IL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Baber Research Group
1700
mi
from 91732
Naperville, IL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Baber Research Group
1700
mi
from 91732
Naperville, IL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Goldpoint Clinical Research
1792
mi
from 91732
Indianapolis, IN
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Goldpoint Clinical Research
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pedia Research, LLC
1724
mi
from 91732
Newburgh, IN
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pedia Research, LLC
1724
mi
from 91732
Newburgh, IN
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Psychiatric Associates
1336
mi
from 91732
Overland Park, KA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Psychiatric Associates
1336
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pedia Research LLC
1736
mi
from 91732
Owensboro, KY
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pedia Research LLC
1736
mi
from 91732
Owensboro, KY
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Neurobehavioral Medicine Group, Clinical Trials Division
1958
mi
from 91732
Bloomfield Hills, MI
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Neurobehavioral Medicine Group, Clinical Trials Division
1958
mi
from 91732
Bloomfield Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Trials group at the Rochester Center for Behavioral Medicine
1963
mi
from 91732
Rochester Hills, MI
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Trials group at the Rochester Center for Behavioral Medicine
1963
mi
from 91732
Rochester Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
213
mi
from 91732
Las Vegas, NV
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
213
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Pharmaceutical Research Associates, Inc.
2388
mi
from 91732
Marlton, NJ
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Pharmaceutical Research Associates, Inc.
2388
mi
from 91732
Marlton, NJ
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
1880
mi
from 91732
Cincinnati, OH
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
University Hospitals at Case Medical Center
2033
mi
from 91732
Cleveland, OH
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
University Hospitals at Case Medical Center
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
IPS Research Company
1165
mi
from 91732
Oklahoma City, OK
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
IPS Research Company
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Cutting Edge Research Group
1162
mi
from 91732
Oklahoma City, OK
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Cutting Edge Research Group
1162
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
BioBehavioral Research of Austin
1208
mi
from 91732
Austin, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
BioBehavioral Research of Austin
1208
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Bayou City Research, Ltd.
1349
mi
from 91732
Houston, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Bayou City Research, Ltd.
1349
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Houston Clinical Trials, LLC
1357
mi
from 91732
Houston, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Houston Clinical Trials, LLC
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Trials of Texas, Inc.
1182
mi
from 91732
San Antonio, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Trials of Texas, Inc.
1182
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Road Runner Research
1182
mi
from 91732
San Antonio, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Road Runner Research
1182
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Family Psychiatry of the Woodlands
1344
mi
from 91732
The Woodlands, TX
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Family Psychiatry of the Woodlands
1344
mi
from 91732
The Woodlands, TX
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Richarmond Behavioral Associates
2426
mi
from 91732
Staten Island, NY
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Richarmond Behavioral Associates
2426
mi
from 91732
Staten Island, NY
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Cyn3rgy Research
823
mi
from 91732
Gresham, OR
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Cyn3rgy Research
823
mi
from 91732
Gresham, OR
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Elite Clinical Trials
53
mi
from 91732
Wildomar, CA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Elite Clinical Trials
53
mi
from 91732
Wildomar, CA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
St. Charles Psychiatric Associates - Midwest Research Group
1557
mi
from 91732
Saint Charles, MO
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
St. Charles Psychiatric Associates - Midwest Research Group
1557
mi
from 91732
Saint Charles, MO
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Coastal Carolina Research Center
2188
mi
from 91732
Mount Pleasant, SC
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Coastal Carolina Research Center
2188
mi
from 91732
Mount Pleasant, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
AVIDA, Inc.
31
mi
from 91732
Newport Beach, CA
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
AVIDA, Inc.
31
mi
from 91732
Newport Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Meridien Research
2140
mi
from 91732
Bradenton, FL
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Meridien Research
2140
mi
from 91732
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Florida Clinical Research Center LLC
2183
mi
from 91732
Maitland, FL
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Florida Clinical Research Center LLC
2183
mi
from 91732
Maitland, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
213
mi
from 91732
Las Vegas, NV
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Center for Psychiatry and Behavioral Medicine, Inc.
213
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated:  1/5/2018
Bayou City Research, Ltd.
1349
mi
from 91732
Houston, TX
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Status: Enrolling
Updated: 1/5/2018
Bayou City Research, Ltd.
1349
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated:  1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
2486
mi
from 91732
New Haven, CT
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Status: Enrolling
Updated: 1/8/2018
Yale Center for Clinical Investigation and Yale Behavioral Pharmacology Laboratory
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated:  1/8/2018
University of North Carolina Hospitals - Meadowmont
2196
mi
from 91732
Chapel Hill, NC
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated: 1/8/2018
University of North Carolina Hospitals - Meadowmont
2196
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated:  1/8/2018
Duke University Medical Center - Center for Living
2203
mi
from 91732
Durham, NC
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease
Status: Enrolling
Updated: 1/8/2018
Duke University Medical Center - Center for Living
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Attachment Based Family Therapy for Suicidal Adolescents
Attachment Based Family Therapy (ABFT) for Suicidal Adolescents
Status: Enrolling
Updated:  1/8/2018
Drexel University
2374
mi
from 91732
Philadelphia, PA
Attachment Based Family Therapy for Suicidal Adolescents
Attachment Based Family Therapy (ABFT) for Suicidal Adolescents
Status: Enrolling
Updated: 1/8/2018
Drexel University
2374
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Impulsivity and Stimulant Administration
Impulsivity and Stimulant Administration
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
Impulsivity and Stimulant Administration
Impulsivity and Stimulant Administration
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Status: Enrolling
Updated:  1/8/2018
Washington University in St. Louis
1568
mi
from 91732
Saint Louis, MO
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Implementation of Evidence-based Treatments for On-campus Eating Disorders
Status: Enrolling
Updated: 1/8/2018
Washington University in St. Louis
1568
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated:  1/8/2018
Hospital for Special Surgery
2434
mi
from 91732
New York, NY
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
Randomized Controlled Trial of Subanesthetic Intravenous Ketamine Infusion in Conjunction With Continuous Epidural Infusion for Treatment of Refractory Complex Regional Pain Syndrome
Status: Enrolling
Updated: 1/8/2018
Hospital for Special Surgery
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
PET Imaging in Cocaine Self Administration
Status: Enrolling
Updated:  1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
PET Imaging in Cocaine Self Administration
Status: Enrolling
Updated: 1/8/2018
Connecticut Mental Health Center
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Mayo Clinic Rochester
1524
mi
from 91732
Rochester, MN
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Mayo Clinic Rochester
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated:  1/9/2018
Franciscan Skemp Hospital
1578
mi
from 91732
La Crosse, WI
Varenicline Treatment for Active Alcoholic Smokers
Varenicline Treatment for Active Alcoholic Smokers
Status: Enrolling
Updated: 1/9/2018
Franciscan Skemp Hospital
1578
mi
from 91732
La Crosse, WI
Click here to add this to my saved trials
Buspirone as a Candidate Medication for Methamphetamine Abuse
Buspirone as a Candidate Medication for Methamphetamine Abuse
Status: Enrolling
Updated:  1/9/2018
University of Kentucky Medical Center
1881
mi
from 91732
Lexington, KY
Buspirone as a Candidate Medication for Methamphetamine Abuse
Buspirone as a Candidate Medication for Methamphetamine Abuse
Status: Enrolling
Updated: 1/9/2018
University of Kentucky Medical Center
1881
mi
from 91732
Lexington, KY
Click here to add this to my saved trials
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
Status: Enrolling
Updated:  1/9/2018
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
Status: Enrolling
Updated: 1/9/2018
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
Status: Enrolling
Updated:  1/9/2018
Yoga Studio
649
mi
from 91732
Albuquerque, NM
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
A Cognitive Behavioral Therapy and Yoga Program for Trauma Symptoms
Status: Enrolling
Updated: 1/9/2018
Yoga Studio
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Psychophysiology of Prolonged Exposure for PTSD With/Without Yohimbine
Status: Enrolling
Updated:  1/10/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
2184
mi
from 91732
Charleston, SC
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) With/Without Yohimbine
Psychophysiology of Prolonged Exposure for PTSD With/Without Yohimbine
Status: Enrolling
Updated: 1/10/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
San Francisco Bay Area Center for Cognitive Therapy
351
mi
from 91732
Oakland, CA
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
San Francisco Bay Area Center for Cognitive Therapy
351
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Institute of Living
2497
mi
from 91732
Hartford, CT
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Institute of Living
2497
mi
from 91732
Hartford, CT
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Alexian Brothers Center for Anxiety and OCD
1707
mi
from 91732
Hoffman Estates, IL
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Alexian Brothers Center for Anxiety and OCD
1707
mi
from 91732
Hoffman Estates, IL
Click here to add this to my saved trials
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated:  1/10/2018
Kansas City Center for Anxiety Treatment, P.A.
1335
mi
from 91732
Overland Park, KA
Using the Canary Breathing System for Panic Disorder Patients
Investigation of the Canary Breathing System for Treating the Symptoms of Panic Disorder
Status: Enrolling
Updated: 1/10/2018
Kansas City Center for Anxiety Treatment, P.A.
1335
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated:  1/10/2018
Regional Network of Programs, Inc.
2474
mi
from 91732
Bridgeport, CT
CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated: 1/10/2018
Regional Network of Programs, Inc.
2474
mi
from 91732
Bridgeport, CT
Click here to add this to my saved trials